PMID- 25087951 OWN - NLM STAT- MEDLINE DCOM- 20150406 LR - 20220318 IS - 1347-5215 (Electronic) IS - 0918-6158 (Linking) VI - 37 IP - 8 DP - 2014 TI - Anti-allergic effect of bee venom in an allergic rhinitis mouse model. PG - 1295-300 AB - Bee venom (BV) has been used as an anti-inflammatory and immune modulating agent in Oriental medicine. This study used a mouse model to investigate the anti-allergic effect of BV, which is used in the treatment of various inflammatory diseases in traditional medicine. BV was obtained from the National Institute of Agricultural Science and Technology of Korea. Female BALB/C mice were sensitized by intraperitoneal injection of ovalbumin (OVA). BV was administered nasally prior to the intranasal instillation of OVA. Allergic behavior, serum OVA-specific immunoglobulin E (IgE), interleukin (IL)-4, IL-10, and interferon-gamma (INF-gamma) levels in nasal lavage fluid were measured. Hematoxylin-eosin and periodic acid-Schiff staining were performed to evaluate histological change. BV attenuated nasal symptoms and inhibited the production of OVA-specific IgE and IL-4 in sensitized mice. The degree of inflammatory cell infiltration and goblet cell hyperplasia was attenuated by BV. Thus, BV effectively reduced allergic inflammation in a mouse model of allergic rhinitis, suggesting its potential as a useful therapeutic agent to treat allergic rhinitis. FAU - Shin, Seung-Heon AU - Shin SH AD - Department of Otolaryngology-Head and Neck Surgery, Catholic University of Daegu. FAU - Kim, Yee-Hyuk AU - Kim YH FAU - Kim, Jeong-Kyu AU - Kim JK FAU - Park, Kwan-Kyu AU - Park KK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - Biol Pharm Bull JT - Biological & pharmaceutical bulletin JID - 9311984 RN - 0 (Allergens) RN - 0 (Anti-Allergic Agents) RN - 0 (Bee Venoms) RN - 0 (Cytokines) RN - 0 (Mucins) RN - 0 (NF-kappa B) RN - 0 (Transcription Factor AP-1) RN - 37341-29-0 (Immunoglobulin E) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Allergens/immunology MH - Animals MH - Anti-Allergic Agents/pharmacology/*therapeutic use MH - Bee Venoms/pharmacology/*therapeutic use MH - Cytokines/immunology MH - Disease Models, Animal MH - Female MH - Immunoglobulin E/blood MH - Mice, Inbred BALB C MH - Mucins/immunology MH - NF-kappa B/immunology MH - Nasal Lavage Fluid/immunology MH - Nasal Mucosa/drug effects/metabolism/pathology MH - Ovalbumin/immunology MH - Rhinitis, Allergic/blood/*drug therapy/immunology MH - Transcription Factor AP-1/immunology EDAT- 2014/08/05 06:00 MHDA- 2015/04/07 06:00 CRDT- 2014/08/05 06:00 PHST- 2014/08/05 06:00 [entrez] PHST- 2014/08/05 06:00 [pubmed] PHST- 2015/04/07 06:00 [medline] AID - DN/JST.JSTAGE/bpb/b14-00102 [pii] AID - 10.1248/bpb.b14-00102 [doi] PST - ppublish SO - Biol Pharm Bull. 2014;37(8):1295-300. doi: 10.1248/bpb.b14-00102.